Details for New Drug Application (NDA): 021514
✉ Email this page to a colleague
The generic ingredient in DAYTRANA is methylphenidate. There are thirty-two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the methylphenidate profile page.
Summary for 021514
Tradename: | DAYTRANA |
Applicant: | Noven Pharms Inc |
Ingredient: | methylphenidate |
Patents: | 3 |
Pharmacology for NDA: 021514
Physiological Effect | Central Nervous System Stimulation |
Medical Subject Heading (MeSH) Categories for 021514
Suppliers and Packaging for NDA: 021514
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DAYTRANA | methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 021514 | NDA AUTHORIZED GENERIC | PADAGIS US LLC | 0574-2410 | 0574-2410-65 | 1 TRAY in 1 CARTON (0574-2410-65) / 30 POUCH in 1 TRAY / 1 PATCH in 1 POUCH / 27.5 mg in 1 PATCH |
DAYTRANA | methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 021514 | NDA AUTHORIZED GENERIC | PADAGIS US LLC | 0574-2415 | 0574-2415-65 | 1 TRAY in 1 CARTON (0574-2415-65) / 30 POUCH in 1 TRAY / 1 PATCH in 1 POUCH / 41.3 mg in 1 PATCH |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | FILM, EXTENDED RELEASE;TRANSDERMAL | Strength | 10MG/9HR (1.1MG/HR) | ||||
Approval Date: | Apr 6, 2006 | TE: | AB | RLD: | Yes | ||||
Patent: | ⤷ Sign Up | Patent Expiration: | Oct 7, 2025 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | ⤷ Sign Up | Patent Expiration: | Oct 7, 2025 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | ⤷ Sign Up | Patent Expiration: | Oct 7, 2025 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | METHOD FOR TRANSDERMALLY DELIVERING A DRUG TO A USER IN NEED THEREOF |
Expired US Patents for NDA 021514
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Noven Pharms Inc | DAYTRANA | methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 021514-002 | Apr 6, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Noven Pharms Inc | DAYTRANA | methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 021514-001 | Apr 6, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Noven Pharms Inc | DAYTRANA | methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 021514-003 | Apr 6, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Noven Pharms Inc | DAYTRANA | methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 021514-003 | Apr 6, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Noven Pharms Inc | DAYTRANA | methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 021514-003 | Apr 6, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Noven Pharms Inc | DAYTRANA | methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 021514-004 | Apr 6, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Noven Pharms Inc | DAYTRANA | methylphenidate | FILM, EXTENDED RELEASE;TRANSDERMAL | 021514-004 | Apr 6, 2006 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription